September 2026 Comm Convo: Beyond the Binder in the Era of Constant Crisis

Jennifer Haslip is a communications and marketing executive with 20+ years of experience building global brands and leading high-performing teams across biotechnology, technology, nonprofit, and research sectors. She currently serves as Head of Research and Science Communications at Google. She previously led Global Corporate Reputation at Gilead Sciences and served as CMO at XPRIZE, where she partnered with the CEO and Board on global communications and impact strategy supporting $400M+ in revenue while building a 19-member global team. Earlier roles include Head of Global Communications at Verily (Alphabet/Google Life Sciences), VP of Communications at the Parker Institute for Cancer Immunotherapy, CMO for Development at Duke University, and VP of Communications and Patient Engagement at St. Jude Children’s Research Hospital, where she led a 40-member team and built the organization’s first integrated entertainment marketing and influencer strategy.

Jennifer is known for strategic communications, reputation management, media relations, and stakeholder engagement that mitigate risk and deliver measurable impact. She recently completed a certificate in AI and Digital Transformation at Stanford’s Graduate School of Business, holds a B.S. in Public Relations from the University of Florida, and serves on the PR Advisory Council for UF’s College of Journalism and Communications.

Stephen serves as Vice President of Global Communications and Investor Relations at the Alliance for Regenerative Medicine (ARM), working closely with journalists, investors, and analysts who cover the biotechnology sector and producing data and analysis to help tell the story of cell and gene therapy. Stephen contributes to ARM’s policy and advocacy objectives in Washington and Brussels and leads issues management on a variety of topics that affect the cell and gene therapy community globally.

Previously, Stephen worked in geopolitical risk consulting at Eurasia Group and was a journalist with the Associated Press covering state politics in Florida and Ohio. He received a bachelor’s degree from Northwestern University and a Master of Public Policy degree from the University of Maryland.

Adam is a Managing Director in Narrative’s New York office. In this role, Adam counsels a wide range of clients across the healthcare sector, with a focus on pharmaceutical and biotechnology companies.

Adam brings nearly two decades of agency experience in healthcare communications, public relations, and thought leadership. He joins Narrative from Scient Public Relations, where he served as Head of Media Relations & Thought Leadership, advising C-suite leaders and corporate affairs teams on corporate reputation, media strategy, and complex scientific communications. Earlier in his career, Adam held roles of increasing seniority at Edelman and Fleishman Hillard, advising pharmaceutical and biotechnology companies ranging from startups to Fortune 500 organizations.

His work spans companies’ most critical moments, including clinical data, regulatory milestones, executive transitions, and sensitive corporate issues. Over the course of his career, Adam has helped executives build lasting relationships with the journalists covering their companies and industries. He operates as a trusted, embedded partner to executive and R&D leadership teams, as well as the reporters who cover their organizations. He takes a modern approach to media relations that incorporates AI/LLMs into message development and measurement, media strategy, and executive communications.

Adam is a lifelong, mostly hopeless fan of the New York Mets. He lives in New Jersey with his wife, daughter, and son. Adam earned his B.A. from the University of Delaware.